Oncology Reviews

OCT 19, 2026 · REVIEW

Narrative review of non-pharmacological interventions for chemotherapy-induced peripheral neuropathy: exercise, physical therapy, cryotherapy and acupuncture

Oncology Reviews

Purpose Chemotherapy-induced peripheral neuropathy (CIPN) is a heterogeneous, treatment-limiting adverse event of cytotoxic chemotherapy that impairs sensory, motor, autonomic and

OCT 19, 2026 · REVIEW

Chinese herbal medicine combined with conventional therapy for gastric precancerous lesions: a systematic review and meta-analysis

Oncology Reviews

Background Chronic atrophic gastritis and gastric precancerous lesions are associated with increased gastric cancer risk. Chinese herbal medicine is widely used as an adjunct to co

OCT 16, 2026 · JOURNAL ARTICLE

Addressing unmet clinical needs in treatment-resistant breast cancer: expanding the diagnostic–prognostic landscape through next-generation inflammatory signatures

Oncology Reviews

Treatment-resistant breast cancer remains a major clinical challenge because conventional clinicopathological and molecular biomarkers incompletely capture the dynamic interactions

OCT 7, 2026 · JOURNAL ARTICLE

The role of personalised medicine in treating high-risk neuroblastoma in paediatric patients

Oncology Reviews

Neuroblastoma (NB) is one of the most challenging paediatric malignancies, accounting for 15% of childhood cancer-related deaths. It is characterised by a high heterogeneity rangin

OCT 5, 2026 · JOURNAL ARTICLE

Treatment of oligometastatic disease in colorectal cancer: from molecular biology to multimodal strategies

Oncology Reviews

The management of oligometastatic colorectal cancer (OMD-CRC) has undergone a profound evolution, transforming what was once a uniformly fatal diagnosis into a clinical scenario in

SEP 16, 2026 · JOURNAL ARTICLE

Adoptive T Cell therapy for cancer and autoimmune disease: current advances, challenges, and future directions

Oncology Reviews

Adoptive T Cell Therapy (ACT) is a kind of immunotherapy that eliminates target cells by autologous T cells. Since the mechanism of adoptive immune was elucidated, ACT has been dev

SEP 8, 2026 · JOURNAL ARTICLE

Engineering probiotic consortia to improve chemotherapy tolerance and reduce toxicity in breast cancer patients: a new frontier in supportive precision oncology

Oncology Reviews

This is a narrative review synthesizing mechanistic rationale and emerging evidence for a novel intervention; it raises questions about engineered probiotic consortia rather than reporting definitive efficacy data from controlled trials.

AUG 7, 2026 · JOURNAL ARTICLE

Acidosis and the role of nanotechnology in mitigating cancer progression

Oncology Reviews

This is a narrative review synthesizing mechanistic concepts and emerging technologies without reporting original data, clinical outcomes, or comparative evidence.